39Followers on Owler

Aligos Therapeutics

Read more
Lawrence M. Blatt's photo - Co-Founder & CEO of Aligos Therapeutics

Co-Founder & CEO

Lawrence M. Blatt

CEO Approval Rating

90/100

Founded

2018

Status

PublicIndependent CompanyNASDAQALGS

Social Links

Annual Revenue
$8.2M
Employees
90
Funding
$375M

Aligos Therapeutics Competitors and Alternatives

1
3
2

Aligos Therapeutics Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$8.2M

Aligos Therapeutics's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 5.4M. Over the last four quarters, Aligos Therapeutics's revenue has grown by 140.3%. Specifically, in Q2 2022's revenue was $3.7M; in Q1 2022, it was $2.6M; in Q4 2021, it was $ < 1M; in Q3 2021, Aligos Therapeutics's revenue was $1.5M.

Aligos Therapeutics News

Aligos Therapeutics Press Releases

Aligos Therapeutics Headquarters

1 Corporate Drive 2nd Floor

San Francisco, California94080

Driving Directions »

Aligos Therapeutics Summary

ABOUT

Overview

Aligos is a preclinical stage biotechnology company that researches and develops novel therapies for hepatologic diseases and viral infections. Aligos Therapeutics was founded in 2018. Aligos Therapeutics' headquarters is located in San Francisco, Cal...

CEO

Aligos Therapeutics's Co-Founder & CEO, Lawrence M. Blatt, currently has an approval rating of 90%. Aligos Therapeutics's primary competitors are NorthSea Therapeutics, Metacrine & Nimbus Therapeutics.

Website

aligos.com

Acquisitions

There have been no acquisitions found related to Aligos Therapeutics

Investments

Recent investment data cannot be found related to Aligos Therapeutics

Frequently Asked Questions about Aligos Therapeutics

  1. When was Aligos Therapeutics founded?

    Aligos Therapeutics was founded in 2018
  2. Who is Aligos Therapeutics's CEO?

    Aligos Therapeutics's CEO is Lawrence M. Blatt
  3. How much revenue does Aligos Therapeutics generate?

    Aligos Therapeutics generates $8.2M in revenue
  4. How much funding does Aligos Therapeutics have?

    Aligos Therapeutics has historically raised $375M in funding
  1. Where is Aligos Therapeutics's headquarters?

    Aligos Therapeutics's headquarters is in San Francisco California, USA
  2. How many employees does Aligos Therapeutics have?

    Aligos Therapeutics has 90 employees
  3. What sector does Aligos Therapeutics operate in?

    Aligos Therapeutics is in Pharmaceuticals, Biotechnology
  4. Who are Aligos Therapeutics's competitors?

    Aligos Therapeutics's top competitors are NorthSea Therapeutics, Metacrine, Nimbus Therapeutics

Trending Companies